Le Lézard
Classified in: Tourism and vacations, Health, Business
Subject: CXP

Dubai Emerges as a Leading Choice for Hair Transplantation Patients Worldwide


Hair of Istanbul Expands Presence to Dubai, Enhancing Access to World-Class Hair Transplantation Services

DUBAI, UAE, March 22, 2024 /PRNewswire-PRWeb/ -- Dubai has rapidly emerged as a global destination for individuals seeking top-notch hair transplantation services, thanks to its advanced medical infrastructure and reputation for excellence in the healthcare sector. As the city continues to attract patients from across the world, its unique blend of cutting-edge technology, expert medical professionals, and luxurious hospitality sets it apart as a preferred choice for those looking to enhance their appearance with hair restoration solutions.

Amidst this growing trend, Hair of Istanbul has strategically positioned itself within this dynamic market by establishing a consultation office in Dubai in 2023. Recognizing the city's potential as a central hub for medical tourism, the expansion aims to serve the clinic's international clientele more effectively, offering them access to some of the best services in hair transplantation without the need to travel extensively.

CEO Mehmet Fatih Akdemir emphasizes the significance of this move, stating, "Dubai's status as a leading destination for medical excellence aligns perfectly with our mission to provide accessible, high-quality hair restoration services. Our presence in Dubai is a step forward in our commitment to meet and exceed the expectations of our patients from around the globe."

Dubai's strategic location, coupled with its renowned hospitality and safety standards, makes it an attractive option for those considering hair transplantation. The availability of experienced professionals and state-of-the-art facilities further assures patients of receiving the best possible care.

By extending its services to Dubai, Hair of Istanbul not only broadens its reach but also enhances the patient experience by making it more convenient for individuals from various regions to access expert consultations and plan their treatment journey with ease.

"Our goal is to offer a seamless and transformative experience to all our patients, starting from the initial consultation to the follow-up care," adds Akdemir. "The Dubai consultation office is an integral part of realizing that vision, ensuring that we continue to set benchmarks in the industry for excellence and patient satisfaction."

With the opening of the consultation office in Dubai, Hair of Istanbul reaffirms its dedication to delivering unparalleled hair transplantation services, contributing to Dubai's growing reputation as a global center for medical tourism, particularly in the field of hair restoration.

Media Contact

Mehmet Fatih Akdemir - CEO, Hair of Istanbul, (+90) 532 650 51 51, [email protected], https://www.hairofistanbul.com/ 

SOURCE Hair of Istanbul


These press releases may also interest you

at 21:00
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

at 20:54
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2...

at 19:56
Rare Cannabinoid Company is proud to announce the launch of its new,...

at 18:58
Children's HealthSM and UT Southwestern Medical Center announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion new Dallas pediatric campus, unveiled earlier this year. The gift from the Pogue...

at 18:45
Amgen will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS)...



News published on and distributed by: